Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date

by Facchinetti F, Friboulet L
Published 2019-09-01

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

by Facchinetti F, Bordi P, Leonetti A, Buti S, Tiseo M
Published 2018-09-01

Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib

by Facchinetti F, Levy A, Ammari S, Naltet C, Lavaud P, Aldea M, Vasseur D, Planchard D, Besse B
Published 2021-03-01

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives

by Rossi G, Jocollé G, Conti A, Tiseo M, Zito Marino F, Donati G, Franco R, Bono F, Barbisan F, Facchinetti F
Published 2017-07-01